Awareness of prediabetes and diabetes among persons with clinical depression

Mary Rosedale, Shiela M. Strauss, Candice Knight, Dolores Malaspina

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Major depressive disorder (MDD) is highly comorbid with diabetes, a relationship underappreciated by clinicians. Purpose: Examine the proportion of nonpregnant individuals ≥20 years with MDD and elevated glucose and the demographic and clinical characteristics associated with unrecognized elevated glucose. Methods: 14,373 subjects who participated in the National Health and Nutrition Examination Survey (2007-2012) completed the PHQ-9 depression screen and had hemoglobin A1C (HbA1c) measured. PHQ-9 scores ≥10 and HbA1c scores ≥5.7% were defned as MDD and elevated HbA1c, respectively. Data were analyzed using complex survey sampling sofware. Results: 38.4% of the sample with MDD had elevated HbA1c readings. Compared with nondepressed subjects, they were significantly more likely to have elevated glucose readings (P = 0.003) and to be aware of their elevated glucose levels if they had a higher body mass index, family history of diabetes, more doctor visits in the past year, a usual care source, health insurance, or were taking hypertension or hypercholesterolemia medications. Conclusions: Many adults with MDD have elevated HbA1c levels, have never been advised of elevated HbA1c, have not received diabetes screening, and have minimal contact with a healthcare provider. Additional opportunities for diabetes risk screening in people with MDD are needed.

Original languageEnglish (US)
Article number839152
JournalInternational Journal of Endocrinology
Volume2015
DOIs
StatePublished - 2015

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems

Fingerprint

Dive into the research topics of 'Awareness of prediabetes and diabetes among persons with clinical depression'. Together they form a unique fingerprint.

Cite this